MedPath

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Not Applicable
Completed
Conditions
Tachycardia
Ventricular Arrhythmias
Interventions
Device: Defibrillation following induction of VT/VF
Registration Number
NCT02772380
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Brief Summary

The main purpose of this clinical study is to collect electrograms from an investigational lead placed in an extravascular space, for development of a future Implantable Cardioverter Defibrillator (ICD) system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Subject must be undergoing surgical procedure for approved indications for:

    • cardiothoracic surgery where a midline sternotomy is planned, or
    • cardiothoracic surgery where a subxiphoid/paraxiphoid cut for a chest tube is planned, or
    • VT ablation procedure with epicardial access, or
    • implant of a subcutaneous ICD (S-ICDยฎ), or implant of a transvenous ICD (single or dual chamber)
  • Subject must be willing to provide Informed Consent

  • Subject must be โ‰ฅ 18 years old

Exclusion Criteria
  • Subject has known hiatus hernia or moderate or worse pectus excavatum

  • Subject had previous pericarditis or prior sternotomy

  • Subject has known significant Right Ventricle/ Right Ventricular dilation

  • Subject has hypertrophic cardiomyopathy

  • Subject is pacemaker dependent

  • Subject has known skin irritations due to the Covidien Multi-function defibrillation electrode

  • Subject is considered to be at high risk for infection(1)

  • Subject has Left Ventricular Ejection Fraction < 20% (most recent available LVEF measurement in the last 6 months)

  • Subject has New York Heart Association Class IV

  • Subject has myocardial infarction within the last 6 weeks

  • Subject currently has unstable angina

  • Subject has severe aortic stenosis

  • Subject at high risk of stroke (2)

  • Subject has Chronic Obstructive Pulmonary Disease and is oxygen dependent

  • Subject has permanent AF and will not be adequately anticoagulated during the ASD2 Acute Testing procedure (3)

  • Subject with an implanted active cardiac or non-cardiac device during the ASD2 Acute Testing procedure (e.g., ICD, S-ICDยฎ, Pacemaker, Neuro stimulator)

  • Subject is enrolled in a concurrent study that may confound the results of this study, without documented pre-approval from a Medtronic study manager

  • Subject has any medical condition that would limit study participation

  • Subject is pregnant, or of childbearing potential and not on a reliable form of birth control. Women of childbearing potential are required to have a negative pregnancy test within 7 days prior to the ASD2 Acute Testing procedure

  • Subject meets exclusion criteria required by local law (e.g. age, breast feeding,etc.)

  • Subject is legally incompetent

    1. Screening subjects at high risk for infection will be based on the local investigator judgment decision.
    2. Subjects who are at high risk for stroke should be screened according to local country guidelines or, in case of their absence, according to ACC/AHA/ESC 2006 Guidelines for High Risk Factors for Stroke (i.e. exclusion of subjects with previous stroke, TIA, or embolism; Mitral stenosis; prosthetic heart valve).
    3. Screening will be based on the local investigator judgment decision.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
VT/ VF induction and defibrillationDefibrillation following induction of VT/VFVentricular Tachycardia and Ventricular Fibrillation (VT/VF) induction and termination through use of a defibrillator, will be carried out as the intervention in all subjects undergoing study procedures.
Primary Outcome Measures
NameTimeMethod
Number of extravascular electrograms collected during ventricular fibrillation or ventricular tachycardia episodesDay of procedure

Collect extravascular EGMs during induced VF/VT and intrinsic rhythms directly from an investigational lead placed in the extravascular space to be used for development of a future ICD.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (36)

Northwestern University

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Baptist Medical Center Jacksonville

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

Iowa Heart Center

๐Ÿ‡บ๐Ÿ‡ธ

Des Moines, Iowa, United States

University of Maryland Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Mayo Clinic (Rochester MN)

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, Minnesota, United States

New York-Presbytarian Hospital / Well Cornell Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Raleigh Cardiology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Raleigh, North Carolina, United States

The Ohio State University Wexner Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Columbus, Ohio, United States

Christchurch Hospital

๐Ÿ‡ณ๐Ÿ‡ฟ

Christchurch, New Zealand

Liverpool Heart and Chest Hospital

๐Ÿ‡ฌ๐Ÿ‡ง

Liverpool, United Kingdom

John Radcliffe Hospital Oxford

๐Ÿ‡ฌ๐Ÿ‡ง

Oxford, United Kingdom

Taichung Veterans General Hospital

๐Ÿ‡จ๐Ÿ‡ณ

Taichung, Taiwan

Hospital Universitario Reina Sofia

๐Ÿ‡ช๐Ÿ‡ธ

Cordoba, Spain

King's College of London

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Southampton General Hospital - University Hospital Southampton NHS Foundation Trust

๐Ÿ‡ฌ๐Ÿ‡ง

Southampton, United Kingdom

London Health Sciences Centre - University Campus

๐Ÿ‡จ๐Ÿ‡ฆ

London, Ontario, Canada

NYU Langone Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Academisch Medisch Centrum (AMC)

๐Ÿ‡ณ๐Ÿ‡ฑ

Amsterdam, Netherlands

Krakowski Szpital Specjalistyczny im. Jana Pawla II

๐Ÿ‡ต๐Ÿ‡ฑ

Krakรณw, Poland

Austin Hospital

๐Ÿ‡ฆ๐Ÿ‡บ

Heidelberg, Victoria, Australia

Royal Columbian Hospital

๐Ÿ‡จ๐Ÿ‡ฆ

New Westminster, British Columbia, Canada

Semmelweis University

๐Ÿ‡ญ๐Ÿ‡บ

Budapest, Hungary

National Taiwan University Hospital

๐Ÿ‡จ๐Ÿ‡ณ

Taipei, Taiwan

Slaskie Centrum Chorob Serca

๐Ÿ‡ต๐Ÿ‡ฑ

Zabrze, Poland

Taipei Veterans General Hospital

๐Ÿ‡จ๐Ÿ‡ณ

Taipei, Taiwan

Arizona Arrhythmia Consultants

๐Ÿ‡บ๐Ÿ‡ธ

Scottsdale, Arizona, United States

Lancaster General Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Lancaster, Pennsylvania, United States

UZ Leuven - Campus Gasthuisberg

๐Ÿ‡ง๐Ÿ‡ช

Leuven, Belgium

Institut Universitaire de Cardiologie et de Pneumologie de Quรฉbec (IUCPQ)

๐Ÿ‡จ๐Ÿ‡ฆ

Quebec City, Quebec, Canada

St. Antonius Ziekenhuis

๐Ÿ‡ณ๐Ÿ‡ฑ

Nieuwegein, Netherlands

Lourdes Cardiology Services

๐Ÿ‡บ๐Ÿ‡ธ

Cherry Hill, New Jersey, United States

Hartford Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Hartford, Connecticut, United States

Universitair Ziekenhuis Gent

๐Ÿ‡ง๐Ÿ‡ช

Gent, Belgium

Maastricht Universitair Medisch Centrum

๐Ÿ‡ณ๐Ÿ‡ฑ

Maastricht, Netherlands

Morristown Memorial Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Morristown, New Jersey, United States

Prince of Wales Hospital

๐Ÿ‡ญ๐Ÿ‡ฐ

Kowloon, Hong Kong

ยฉ Copyright 2025. All Rights Reserved by MedPath